Although the role of up/downregulation of Piezo1 in neurodegenerative diseases still has to be fully elucidated, data suggest that this channel could be a new important therapeutic target for AD and other neurodegenerative diseases [216,217,218]. Here, PIEZO1 is linked to Alzheimer disease.